Los Angeles Talc Trial: Johnson & Johnson Knew About Asbestos in 1973 — and Three Women Are Dead
If your mother, your wife, your sister used Johnson & Johnson baby powder for years — for decades — and then died of ovarian cancer, you are reading this at a kitchen table at two in the morning with a question that will not let you sleep: did the powder do it? And if it did, did the company know?
In a Los Angeles courtroom right now, a jury is hearing the answer to both questions. Three families brought their cases together in one trial because three women — three mothers, wives, people with names and histories and people who loved them — died of ovarian cancer after long-term use of Johnson & Johnson’s talc-based baby powder. And in front of that Los Angeles County jury, an attorney held up a document from 1973.
It is an internal Johnson & Johnson memo. In it, executives discussed reports that found asbestos in talc mines. They considered safer alternatives — corn starch. They knew. Fifty years ago, they knew. And they kept selling talc.
That memo is the spine of this trial. It is also the reason you need to understand what is happening in that courtroom — because what the jury decides there will shape what happens to families like yours across California and across the country. We are Attorney911 — The Manginello Law Firm. We are a trial firm that takes California cases. We are not the lawyers in that courtroom. But we know this law, this evidence, and this fight the way a surgeon knows the body on the table. This page is everything we would tell you if you called us tonight.
What Is Happening in This Los Angeles Trial
The trial now underway in Los Angeles Superior Court is the second bellwether in California’s coordinated state-court talc proceedings against Johnson & Johnson. A bellwether is a test case — the court picks representative cases to try first so that the evidence, the rulings, and the jury’s reaction set the direction for everything that follows.
The first bellwether in this same California proceeding ended on December 12 with a $40 million verdict for the plaintiff. A single case. One woman. One jury. Forty million dollars.
Now three families have their cases combined into this second bellwether. Three women. Three decades of baby powder use. Three ovarian cancer deaths. And the same 1973 memo sitting in the evidence pile.
The scale of this litigation is staggering. In the federal multidistrict litigation consolidated in New Jersey — a separate track from these California state-court cases — more than 68,000 talc claims were pending as of mid-2026. Johnson & Johnson has tried three times to push those cases into bankruptcy through a corporate maneuver called the “Texas two-step,” creating a shell entity to absorb the liability and then filing for Chapter 11. Three times, courts threw it out. The third attempt was dismissed on March 31, 2025, by a federal bankruptcy judge in Texas who found vote-solicitation irregularities and improper nonconsensual releases. The cases are back in the court system — where Johnson & Johnson has to face juries.
This Los Angeles trial is one of those fights. And the 1973 memo is the weapon.
California’s Strict Products Liability Law: Why This State Is Different
California is one of the strongest jurisdictions in the country for a person injured by a defective product. The reason goes back to a 1963 California Supreme Court decision that changed American product liability law — a case that established what lawyers call the Greenman doctrine. Under that doctrine, you do not have to prove the company was negligent. You do not have to prove it was careless. You have to prove three things: the product was defective, the defect existed when it left the company’s control, and the defect caused your injury.
“California is a strict products liability jurisdiction under the Greenman doctrine, which eliminates the need to prove negligence for manufacturing, design, and warning defects — plaintiffs need only show the product was defective, the defect existed when it left the defendant’s control, and the defect caused the injury.”
That is the law. In plain English: Johnson & Johnson does not get to argue “we were careful” and walk away. If the product was defective — if the talc was contaminated with asbestos, or if the design was dangerous when a safer alternative existed, or if the warnings were inadequate — and that defect caused the cancer, the company is responsible. Period.
California applies two tests for design-defect claims. The consumer expectation test asks whether the product performed as safely as an ordinary consumer would expect. Baby powder marketed as pure, gentle, and safe for babies — if it contained asbestos, it did not perform as anyone expected. The risk-benefit test asks whether the dangers of the design outweighed its benefits, and whether a feasible safer alternative existed. The 1973 memo is a direct hit on that test — Johnson & Johnson’s own executives discussed corn starch as a safer alternative and chose not to switch.
For failure-to-warn claims, California requires proof that inadequate warnings were a substantial factor in causing harm. Johnson & Johnson marketed this product for decades as pure and safe. The 1973 memo shows they knew about asbestos contamination and said nothing to consumers.
Here is the part that matters most for what your case may be worth: California imposes no statutory cap on non-economic or punitive damages in products liability cases. The damage caps that exist in California under MICRA — the Medical Injury Compensation Reform Act — apply only to medical malpractice actions. They do not touch toxic tort or product liability claims. A jury in Los Angeles that finds Johnson & Johnson liable for a woman’s ovarian cancer death can award the full measure of pain, suffering, loss of companionship, and punishment — with no statutory ceiling.
If you or a loved one has been diagnosed with ovarian cancer or mesothelioma after long-term talcum powder use, our toxic tort practice handles cases built on this exact legal framework.
The 1973 Memo: What Johnson & Johnson Knew and When They Knew It
In 1973, Johnson & Johnson executives circulated an internal memo discussing reports that found asbestos in talc mines. The memo shows that the company was aware of asbestos contamination in the raw material it used to make baby powder — a product it marketed to parents for use on infants.
The memo also shows the company considered safer alternatives. Corn starch was discussed. Corn starch does not contain asbestos. Corn starch does not cause mesothelioma. Corn starch was feasible, available, and already used by other companies in similar products.
Johnson & Johnson chose to keep using talc.
That single document does five things in a courtroom:
First, it proves corporate knowledge. The company cannot argue it did not know asbestos contaminated talc. Its own executives were discussing it in 1973 — more than fifty years ago.
Second, it proves a feasible safer alternative existed. Under California’s risk-benefit test for design defect, the existence of a safer alternative that the manufacturer chose not to adopt is powerful evidence that the design was defective. Corn starch was on the table in 1973. Johnson & Johnson left it there.
Third, it supports fraudulent concealment. If the company knew about the risk and deliberately chose not to disclose it to consumers, regulators, or the scientific community — while continuing to market the product as pure and safe — that is not just negligence. That is the kind of conduct that opens the door to punitive damages under California law.
Fourth, it anchors the timeline. Every woman who used this product after 1973 used a product made by a company that already knew about the asbestos risk. The memo ties the knowledge to the exposure period.
Fifth, it tells the jury a story. Jurors do not just weigh evidence — they decide whether a company behaved the way they believe a responsible company should. A fifty-year-old memo discussing a known carcinogen in a baby product, followed by decades of marketing that product as pure and gentle, is the kind of story that changes how a jury sees everything else in the case.
The defense will argue the memo is being taken out of context. They will argue the executives were just being cautious. They will argue the asbestos levels were negligible. But the memo exists. It says what it says. And a Los Angeles jury is reading it.
Who Can Be Held Responsible: Johnson & Johnson’s Corporate Structure
Johnson & Johnson is not one company. It is a corporate family — and understanding that family is the first step in holding the right entities accountable.
Johnson & Johnson (the parent corporation) designed, manufactured, marketed, and distributed the talc-based baby powder. The 1973 memo came from its executives. The decision to continue using talc despite knowledge of asbestos contamination was a corporate decision made at the top.
Johnson & Johnson’s consumer products division was the operating entity responsible for the baby powder product line. It controlled the formulation, the quality testing, the labeling, and the consumer-facing safety marketing. In 2023, Johnson & Johnson spun off its consumer health business into a separate publicly traded company called Kenvue — the entity that now owns brands like Band-Aid, Tylenol, and Listerine. But Johnson & Johnson retained indemnity obligations for talc liability. The corporate restructuring does not erase responsibility for decades of conduct.
Talc raw material suppliers are a separate discovery target. The talc that went into Johnson & Johnson’s baby powder came from mines — mines where asbestos contamination was documented. The companies that mined, processed, and supplied that talc to Johnson & Johnson face their own potential liability for sending contaminated raw material into the consumer supply chain. Their identities emerge through supply-chain discovery.
And then there is the bankruptcy shell game. Johnson & Johnson created an entity called LTL Management LLC to absorb the talc liability, then filed it for Chapter 11 bankruptcy — a maneuver designed to freeze all lawsuits and force claimants into a settlement fund. When that was dismissed, they tried again with Red River Talc LLC. When that was dismissed, they tried a third time. Each attempt failed. Each attempt was a corporate strategy to avoid facing juries.
The reason this matters to you: the entity on the label is not always the entity with the money or the entity that made the decisions. A thorough case names the right defendants — the parent, the operating division, the suppliers — and traces the liability to where the assets and the decisions actually sit. Johnson & Johnson’s collectibility is essentially unlimited given its corporate assets and insurance depth. Any verdict against it is fully recoverable absent post-trial reduction or appellate reversal.
The Science: Talc, Asbestos, and Ovarian Cancer
Talc and asbestos are minerals that are geologically related. They form in the earth under similar conditions, and talc deposits frequently contain asbestos fibers. Not all talc is contaminated — but the talc that comes from mines where asbestos is present can carry those fibers into the final product.
When a woman uses talcum powder for personal hygiene — particularly in the genital area, as baby powder was marketed for decades — the particles can travel through the reproductive tract. If those particles include asbestos fibers, the body cannot break them down. The fibers lodge in tissue, cause chronic inflammation, and over years or decades can contribute to the development of cancer.
The scientific battleground in these cases has two layers:
General causation — does talc use, particularly talc contaminated with asbestos, cause ovarian cancer? This is where the 1973 memo matters most. The company’s own executives were discussing asbestos in talc mines in 1973. Epidemiological studies have examined the association between perineal talc use and ovarian cancer, with multiple studies finding an elevated risk. The International Agency for Research on Cancer has classified perineal use of talc-based body powder as “possibly carcinogenic to humans” (Group 2B). The defense argues the science is not settled. The plaintiffs’ experts argue the body of evidence — the studies, the biological mechanism, the corporate documents — is more than enough to meet the standard for a jury.
Specific causation — did talc use cause this particular woman’s ovarian cancer? This is where the defense fights hardest. Ovarian cancer has multiple risk factors — age, genetics, family history, reproductive history, hormone use. The defense will argue each woman’s cancer could have come from another source. The counter requires building a specific exposure history for each decedent: what product she used, how often, for how many years, and matching that exposure timeline to her cancer diagnosis and disease progression.
This is why the trial strategy in a combined three-plaintiff case is both powerful and risky. The 1973 memo is powerful across all three cases — it proves corporate knowledge that applies to every user. But each woman’s specific exposure history and medical timeline must be individually proven. If the evidence is strong for one plaintiff and weak for another, the defense will move to sever — to separate the cases so the weaker ones do not benefit from the stronger ones. The plaintiffs’ counsel must preemptively marshal specific exposure evidence for each decedent to defeat any severance motion.
The Medicine: What Ovarian Cancer Does to a Woman and Her Family
Ovarian cancer is one of the most lethal gynecologic malignancies — not because it is untreatable, but because it is usually found late. The symptoms are vague: bloating, pelvic pain, feeling full quickly, urinary urgency. They are symptoms women live with for months, sometimes years, before anyone orders the imaging that reveals a mass. By the time ovarian cancer is diagnosed, it has often already spread beyond the ovaries.
The disease trajectory that follows is brutal. Diagnostic uncertainty gives way to surgical staging — usually a total abdominal hysterectomy with bilateral salpingo-oophorectomy, often with debulking of visible tumor throughout the abdomen. Then chemotherapy — typically a platinum-based regimen like carboplatin paired with paclitaxel, given in cycles over months. The side effects are cumulative: nausea, fatigue, neuropathy in the hands and feet that can become permanent, hair loss, immunosuppression that turns a common cold into a hospitalization.
For many women, the cancer responds at first. Tumors shrink. Tumor markers drop. There is a period of hope. Then the cancer comes back. Recurrent ovarian cancer is treated with additional chemotherapy, targeted therapies, PARP inhibitors, and eventually, when options run out, with palliative care focused on quality of life rather than cure.
The final phase is what survival damages are built from. The pain. The weight loss. The ascites — fluid accumulation in the abdomen that makes breathing difficult and requires repeated drainage. The gradual withdrawal from the life she had. The conversations with family about what comes next. The fear. The dignity lost in a hospital bed. The death.
Under California law, a survival claim carries the decedent’s pre-death pain, suffering, and medical expenses. The wrongful death claim carries the family’s loss — the financial support she would have provided, the companionship, the guidance, the love that was taken.
The defense will argue the cancer was caused by something else — genetics, age, hormones. They will point to BRCA mutations, to family history, to reproductive factors. The counter lives in the timeline: a woman with decades of perineal talc exposure, no significant genetic risk factors, and a cancer diagnosis that fits the exposure pattern. The medical records, the pathology reports, the treatment history, the oncologist’s testimony — these are the proof.
What Your Case May Be Worth
The first California bellwether produced a $40 million verdict for a single plaintiff. This second bellwether combines three wrongful death cases with the 1973 memo as the centerpiece of corporate knowledge.
Based on the characteristics of this case — three combined wrongful death claims, a strong corporate-knowledge narrative, catastrophic outcomes, a Los Angeles venue with a diverse jury pool, and California’s strict products liability framework with no damages caps — the case value range runs from approximately $30 million on the low end to $150 million or more on the high end.
The low end accounts for the defense prevailing on causation for one or more plaintiffs, or a conservative jury. The high end reflects three full liability findings with punitive damages.
Here is how those numbers are built:
Economic damages include past medical treatment costs — the surgeries, the chemotherapy, the hospitalizations, the imaging, the doctor visits, the medications. They include lost earnings and earning capacity — the income these women would have earned over their remaining working lives. They include funeral and burial expenses. These are calculable from records.
Non-economic damages include each decedent’s pre-death pain and suffering — the survival claim. They include each family’s loss of love, companionship, comfort, care, society, affection, and moral support — the wrongful death claim. In California, there is no statutory cap on these damages in a products liability case. The jury decides what a life is worth.
Punitive damages are available under California law upon a showing of malice, oppression, or fraud. The 1973 memo — corporate knowledge of asbestos contamination, followed by fifty years of marketing the product as pure and safe — is designed to meet that standard. If the jury finds by clear and convincing evidence that Johnson & Johnson acted with malice or fraud, the punitive award can be substantial. And because California imposes no cap on punitive damages in products liability cases, the jury’s judgment is the judgment.
For context: in a separate talc trial in Missouri, a jury awarded 22 plaintiffs $4.69 billion against Johnson & Johnson in 2018. The Missouri Court of Appeals reduced that to approximately $2.12 billion. The United States Supreme Court declined to review the reduction in June 2021. That reduced verdict stands as one of the largest affirmed talc verdicts in history — and it is public record, not our case.
Past results depend on the facts of each case and do not guarantee future outcomes. What we can tell you is that the $40 million first bellwether in California’s coordinated proceedings, the $2.12 billion affirmed Missouri verdict, and the strength of the 1973 memo evidence create a serious settlement and trial posture for anyone with a qualifying talc claim.
The Evidence Clock: What Records Exist and How Fast They Disappear
In a talc-ovarian cancer case, the evidence is not on a six-month timer the way a truck’s electronic logs are. But it is still perishable — and the clock runs differently depending on what kind of evidence we are talking about.
The 1973 internal Johnson & Johnson memo is already preserved — it is a trial exhibit in the current Los Angeles proceeding. This document is not going to disappear. But it is not the only corporate document that matters.
Historical Johnson & Johnson testing and quality-control records (1960s through the present) establish what the company knew about asbestos contamination levels across decades. These records are in Johnson & Johnson’s custody. Document retention policies may have destroyed older records. Any extant records must be demanded through discovery immediately. These are the records that show whether J&J tested its talc for asbestos, what it found, and whether it disclosed those findings to anyone.
Talc mine sourcing and supply-chain records identify which mines supplied Johnson & Johnson’s talc and what their known asbestos contamination profiles were. Decades-old supply-chain records may be partially destroyed. A document hold and targeted discovery demand must go out immediately.
Decedents’ medical and oncology treatment records document the ovarian cancer diagnosis, treatment course, disease progression, and causation timeline. Medical providers retain records for limited periods under California regulations. These must be obtained immediately through authorization or subpoena before destruction.
Decedents’ product purchase history and usage evidence establishes the duration, frequency, and pattern of talc exposure — the specific causation evidence. Family testimony about usage habits, receipts, and product containers with lot numbers are critical. Physical evidence degrades over time. Family recollection fades. Product containers should be photographed and preserved immediately.
Johnson & Johnson marketing, advertising, and promotional materials spanning decades demonstrate how the company represented product safety and purity to consumers. These materials may exist in corporate archives but may require aggressive motion practice to compel production. The contrast between the 1973 internal memo and decades of “pure and gentle” marketing is the heart of the fraudulent-concealment and failure-to-warn claims.
FDA correspondence, inspection records, and talc testing results show regulatory awareness and any enforcement or non-enforcement actions. Federal agency records are available through FOIA requests, but FOIA processing times can stretch for months or longer. These requests must be filed early.
The preservation letter — the document that orders Johnson & Johnson and any other potential defendant to freeze all relevant records — goes out the day you call a lawyer. Not the month. Not the season. The day. Because every day that passes is a day closer to a records-destruction cycle, a memory that fades, or a product container that gets thrown out.
The Defense Playbook: What Johnson & Johnson Will Do — and How Each Move Is Countered
Johnson & Johnson’s defense team is one of the most sophisticated in the world. They have tried these cases before. They know what works. Here are the plays they run — and the counter to each one.
Play 1: “The Science Is Not Settled”
Johnson & Johnson argues the link between talc use and ovarian cancer is not proven. They point to studies they say show no association. They argue the scientific evidence is mixed and inconclusive.
The counter: The 1973 memo proves corporate knowledge. Multiple epidemiological studies found an elevated risk of ovarian cancer with perineal talc use. The biological mechanism — particles traveling through the reproductive tract, causing chronic inflammation — is established. And under California’s strict products liability framework, the jury does not need to be certain beyond a reasonable doubt. They need to find that the defect was a substantial factor in causing the injury. The plaintiffs’ experts — a mineralogist who can testify about asbestos in talc, an epidemiologist who can testify about the association, and a treating oncologist who can tie the specific cancer to the exposure — are the answer to this play.
Play 2: “The FDA Never Banned Talc”
Johnson & Johnson argues the U.S. Food and Drug Administration never banned talc in cosmetics, never required a warning, and never found asbestos in their specific product. They frame regulatory compliance as proof of safety.
The counter: California law is explicit on this point. Compliance with regulatory minimums does not establish the adequacy of warnings under California products liability law. The FDA’s regulation of cosmetics is notoriously light — cosmetic products do not require premarket approval. The FDA has conducted surveys and testing for asbestos in cosmetic talc products and has issued guidance on testing methodologies, but it has not enacted a ban. The absence of a federal ban is not a stamp of safety. It is a gap in regulation. And a jury in California is allowed to find that a product was dangerous even when the government did not step in to say so.
Play 3: “Something Else Caused the Cancer”
Johnson & Johnson points to alternative causes — BRCA gene mutations, family history of ovarian or breast cancer, age, reproductive history, hormone therapy. They argue each woman’s cancer was the result of factors unrelated to talc.
The counter: Specific exposure history. How many years did she use the product? How often? Where on her body? What brand? When was she diagnosed? Were there genetic risk factors — and if not, what explains the cancer in a woman with no family history and no genetic predisposition? The treating oncologist’s testimony, combined with the exposure timeline and the absence of alternative explanations, is how specific causation is proven. The defense does not get to say “maybe something else caused it” without offering evidence that something else actually did.
Play 4: “These Cases Should Be Tried Separately”
Johnson & Johnson moves to sever the three cases, arguing that individual causation evidence varies and that combining them unfairly prejudices the jury.
The counter: Preemptively marshal specific exposure evidence for each decedent. If each woman has a strong, documented usage history and a cancer timeline consistent with the exposure, the case for joinder is strong. The common evidence — the 1973 memo, the corporate knowledge, the marketing — applies equally to all three. The individual evidence — the specific product usage, the medical timeline — is what defeats the severance motion.
Play 5: The Quick Settlement Offer
Johnson & Johnson may approach families with a settlement offer that sounds large but is a fraction of what the case is worth — designed to close the file before the family understands the full value of the claim, especially the punitive damages posture created by the 1973 memo.
The counter: The $40 million first bellwether verdict provides a data point for what California juries are doing in these cases. The $2.12 billion affirmed Missouri verdict — reduced from $4.69 billion but still the largest affirmed talc verdict in history — provides another. The 1973 memo creates a punitive damages exposure that a quick settlement is designed to make disappear. A case is not settled fairly until every category of damage is valued: economic, non-economic, and punitive. Premature mediation is how strong cases get undervalued.
How a Talc Case Is Actually Built
Here is the chronological walk of how a talc-ovarian cancer case is constructed — from the first call to the courtroom.
Week one: the preservation letter goes out. Johnson & Johnson, any talc suppliers identified through initial research, and any other potential defendants receive a written demand to preserve all relevant records — testing data, supply-chain documents, marketing materials, internal communications, FDA correspondence. This letter is what converts routine records-destruction into spoliation. If records disappear after the letter is on file, the jury can be told to assume the missing records contained the worst the plaintiff claims.
Weeks two through four: medical records collection. The decedent’s complete oncology file is obtained — pathology reports, surgical notes, chemotherapy records, imaging, tumor-marker history, treating-physician notes. These establish the cancer diagnosis, the treatment course, the disease progression, and the survival period for damages calculation.
Month one through three: exposure reconstruction. Family members are interviewed about the decedent’s talc use — which products, what frequency, what duration, what application method. Product containers are photographed. Purchase receipts are gathered. Pharmacy and store records are pulled where available. This is the specific causation evidence.
Months three through six: expert selection and retention. A mineralogist or analytical chemist is retained to testify about asbestos contamination in talc and the likelihood that the specific product contained asbestos fibers. An epidemiologist is retained to testify about general causation — the association between talc use and ovarian cancer. The treating oncologist is prepared to testify about specific causation — connecting this woman’s cancer to her exposure history. A life-care planner or forensic economist may be retained to build the damages model.
Months six through twelve: discovery. Document production from Johnson & Johnson — internal testing records, supply-chain documents, marketing archives, executive communications. Depositions of corporate witnesses — the executives, the scientists, the marketing directors who decided to keep selling talc after 1973. The depositions are where the 1973 memo comes alive — when a corporate witness has to explain, under oath, why the company knew about asbestos in its talc and chose not to switch to corn starch.
Year one and beyond: motions, trial preparation, and trial. Expert challenges under California’s evidentiary standards — the defense will try to keep the plaintiffs’ experts from testifying. Motions to sever — the defense will try to separate the cases. Motions in limine — both sides fight over what the jury sees and hears. Then trial — the 1973 memo held up in front of twelve people from Los Angeles County who decide whether Johnson & Johnson is responsible for what happened to these women.
This is not a fast process. But the number at the end is built from all of it — from the records that were preserved, the experts who were retained, the depositions that were taken, and the corporate knowledge that was proven. Every step matters. The first step is the call.
Your First Steps: What to Do and What Not to Do
If you believe your loved one’s ovarian cancer may be connected to long-term talcum powder use, here is what you should do — and what you should not do.
Do preserve product containers. If you still have bottles or containers of the talcum powder your loved one used, do not throw them away. Photograph them from every angle. Preserve the packaging — the lot numbers, the labeling, the marketing language. These are physical evidence. They establish which specific product was used and, through the lot number, can potentially tie the product to a specific manufacturing batch and supply source.
Do gather medical records. Obtain the complete oncology file — pathology reports, surgical notes, chemotherapy records, imaging studies, physician notes, hospital discharge summaries. These documents are on a retention clock at medical providers. Request them in writing. If your loved one has passed, you may need to obtain them through the estate or through an authorization from the personal representative.
Do document the usage history. Write down everything you know about your loved one’s talc use — which brand, how often, where on the body, starting when, ending when, who else in the household used it. Talk to other family members. Their recollections matter. The usage history is the foundation of specific causation.
Do act on the statute of limitations. California has a two-year statute of limitations for personal injury and wrongful death actions. For toxic tort cases involving latent disease — cancer that develops years or decades after exposure — the discovery rule may apply, meaning the clock may not start until you knew or reasonably should have known that the cancer was connected to the product. But the discovery rule is not a guarantee, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. The only safe move is to talk to a lawyer early — while the clock and the evidence are both still alive.
Do not discuss the case on social media. Defense investigators monitor plaintiff family communications for impeachment material. A Facebook post about the case, a tweet about the settlement, an Instagram photo of the courthouse — any of these can be taken out of context and used against you.
Do not contact Johnson & Johnson or its representatives. If the company or its insurers contact you — and they may, with a friendly voice and a quick offer — do not speak with them. Do not sign anything. Do not give a recorded statement. Everything you say to them can and will be used to minimize your claim.
Do not speak with media without coordinating through counsel. The defense watches. The case is tried in the courtroom, not in the press.
Do call. The preservation letter, the medical-records demand, the FOIA request to the FDA — these all take time, and they all have clocks. The day you call is the day those clocks start working for you instead of against you.
Frequently Asked Questions
Can I still file a talc lawsuit if my loved one died years ago?
It depends on when you learned — or when you should have learned — that the cancer might be connected to talc use. California has a two-year statute of limitations for wrongful death and personal injury claims, but for toxic tort cases involving latent disease, the discovery rule may extend the deadline. The clock may not start until you knew or reasonably should have known that the talc caused the cancer. If you only recently learned of the connection — through news coverage of these trials, through a doctor’s suggestion, through a conversation with a friend — your case may still be alive. But this is a question that must be answered by a lawyer who can evaluate the specific facts. Do not assume you have plenty of time. Do not assume it is too late. Call and find out.
How long does a talc lawsuit take?
These are not fast cases. From the first filing to a verdict can take one to three years or more, depending on the court’s docket, the complexity of the case, the number of defendants, and whether the case is part of a coordinated proceeding like the one in Los Angeles. Some cases settle before trial. Others go to verdict and then through post-trial motions and appeal. A final resolution can extend well beyond the trial date. But the evidence-preservation steps happen in the first weeks — which is why the timeline starts the day you call, not the day the trial begins.
Does it matter that Johnson & Johnson tried to use bankruptcy?
It matters a great deal — and it helps the plaintiffs. Johnson & Johnson attempted three times to push talc liability into a bankruptcy shell entity, and three times the courts rejected the maneuver. The last dismissal came in March 2025. The cases are back in the tort system, where Johnson & Johnson has to face juries. The bankruptcy strategy tells a jury something about the company’s approach to these claims — it would rather restructure than answer in open court. And it tells you something: the company sees enough liability in these cases to spend millions trying to avoid a courtroom. The bankruptcy is over. The trials are happening.
What if my loved one used generic or store-brand talcum powder?
Johnson & Johnson is the most visible defendant in talc litigation, but it is not the only one. Store-brand and generic talcum powders were also made from talc — and if that talc was contaminated with asbestos, the manufacturer of those products faces the same liability. The supply chain is a discovery target: the companies that mined the talc, processed it, and sold it to whoever put it in the bottle. If your loved one used a different brand, the case may look different — but the science, the regulatory framework, and the legal theories are the same. The product identification step is where we determine which defendants to name.
What if my loved one had other risk factors for ovarian cancer?
Having other risk factors does not eliminate the claim — but it does make the specific-causation fight harder. Ovarian cancer risk factors include age, family history, BRCA gene mutations, reproductive history, and hormone therapy use. The defense will point to every risk factor your loved one had and argue it — not the talc — caused the cancer. The counter requires a careful exposure analysis: if she had no significant genetic risk factors, if the exposure was long and heavy, if the cancer type and timeline are consistent with the exposure pattern, the case is still strong. The eggshell-plaintiff doctrine — which California follows — means the defendant takes the victim as found. A pre-existing vulnerability does not reduce the defendant’s liability; it may enlarge the damages.
Is there a deadline to file if I just learned about the talc-cancer connection?
Possibly — and this is one of the most important reasons to call a lawyer now. California’s two-year statute of limitations for personal injury and wrongful death may be tolled (paused) under the discovery rule until you knew or should have known of the connection between the cancer and the talc. But “should have known” is a legal standard, not a personal feeling. The defense will argue you should have known earlier — that the connection was publicly reported years ago, that a doctor mentioned it, that you saw a commercial. The earlier the defense says you should have known, the earlier the clock starts — and if the clock has already run, the case is gone. The only way to know where you stand is to have a lawyer evaluate the specific facts of your timeline. This is not something to figure out alone.
What does it cost to hire a lawyer for a talc case?
We work on contingency. That means we do not get paid unless we win your case. The fee is 33.33% of the recovery if the case resolves before trial, and 40% if the case goes to trial. The consultation is free. The first phone call costs nothing. We do not send a bill for the investigation, the records collection, or the expert review. Those costs are advanced by the firm and recovered from the recovery if there is one. If there is no recovery, you owe us nothing for attorney’s fees. This is how we make sure that a family’s ability to pursue justice does not depend on their bank account.
What if I live outside California but my loved one used the product in California?
Venue — where the case is filed — depends on where the injury occurred, where the defendant does business, and where the plaintiff lives. California’s strict products liability framework and its lack of damages caps make it a favorable venue, but whether your case belongs in California depends on the specific facts. If your loved one lived in California, used the product in California, and was diagnosed in California, the case likely belongs here. If she lived in another state, the case may need to be filed there — under that state’s laws, which may differ from California’s in important ways. This is a threshold question that must be answered at intake.
Why This Firm
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes California cases, working with local counsel where required. We do not have an office in California, and we do not claim a California bar admission. What we have is 27 years of courtroom experience, a track record of millions recovered for injured people, and the specific knowledge of how toxic tort and product liability cases are built and tried.
Ralph Manginello is our managing partner — 27 years licensed, admitted in Texas state and federal court, a journalist before he was a lawyer, a competitor who hates losing. He has spent his career in courtrooms, including federal court, and he approaches every case with the instinct of a reporter: find the document that proves what the company knew and when they knew it. The 1973 memo is exactly the kind of evidence he goes looking for.
Lupe Peña is our associate attorney — a former insurance-defense attorney who spent years inside a national defense firm, in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like the families in these talc cases. He knows how the other side values a claim, how they pick their experts, and how they build their defenses — because he used to do it. Now he uses that knowledge for injured clients. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter.
We serve families in English and Spanish. Hablamos Español. Your family should not need a translator to understand their legal rights.
We offer a free consultation, 24 hours a day, 7 days a week. You will speak to a live person, not an answering service. The call costs nothing. The consultation costs nothing. We do not get paid unless we win your case.
If your mother, your wife, your sister used Johnson & Johnson baby powder for years and died of ovarian cancer — if you are sitting at a kitchen table at two in the morning with a question that will not let you sleep — the 1973 memo may be the answer. Johnson & Johnson knew. Fifty years ago, they knew.
The question now is what you do with that knowledge.
Call us at 1-888-ATTY-911 — that is 1-888-288-9911. Or contact us online. The consultation is free. The call is confidential. And the day you call is the day the evidence starts working for you instead of disappearing.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential.